Inactive Instrument

HINTO Energy, Inc. Share Price Other OTC

Equities

HENI

US4334751009

Investment Holding Companies

Sales 2013 0.07 5.23 Sales 2014 0.48 37.92 Capitalization 9.93M 792M
Net income 2013 -1M -79.72M Net income 2014 -2M -159M EV / Sales 2013 249,669,329 x
Net Debt 2013 590K 47.05M Net Debt 2014 2.6M 207M EV / Sales 2014 26,351,704 x
P/E ratio 2013
-10.1 x
P/E ratio 2014
-4.28 x
Employees -
Yield 2013 *
-
Yield 2014
-
Free-Float 52.9%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 07/06/23
Chief Operating Officer - 06/03/23
Chief Tech/Sci/R&D Officer 68 06/03/23
Members of the board TitleAgeSince
Chief Executive Officer - 07/06/23
More insiders
Hinto Energy, Inc., through its rights in JF BioPharma, Inc., is a developer of synthetic late stage schedule1 drugs. The Company’s focus is on synthetic cannabinoids to treat fibromyalgia, wound care, Type 2 diabetes and cystic fibrosis (CF).
More about the company